Comments
Dr. Reddy’s Laboratories Ltd has launched Levocetirizine Dihydrochloride tablets, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy 24HR tablets, in the US market. Xyzal is a registered trademark of the UCB group of companies.
Levocetirizine Dihydrochloride tablets are an over-the-counter antihistamine used for 24-hour relief from allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. "This first-to-market launch for the store brand is the testament to the deep capabilities of our store brand OTC business,” Milan Kalawadia, Vice-President and Head, US Over-the-Counter and Speciality Rx businesses, Dr. Reddy’s Laboratories, said in a release issued here on Friday.
``We look forward to collaborating with our customers to bring high-quality, affordable store brand alternatives to the market.” The Xyzal Allergy 24HR tablets brand had US sales of approximately $71 million for the most recent 12 months ending in January 2018, according to IRI. Dr. Reddy’s Levocetirizine Dihydrochloride Tablets USP is available in 5 mg strength and in various consumer-oriented package sizes.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.